El-ASSAL MI, SAMUEL D. OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS. Int J Pharm Pharm Sci [Internet]. 2022 Jan. 1 [cited 2024 Nov. 20];14(1):17-2. Available from: https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/43145